Related Experiment Video
Updated: Apr 9, 2026
08:38
Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
Published on: August 16, 2019
30.0K
Systemic inflammatory response following acute myocardial infarction
Lu Fang1, Xiao-Lei Moore1, Anthony M Dart2
1Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia.
Journal of Geriatric Cardiology : JGC
|June 20, 2015
Summary
Acute myocardial infarction (AMI) triggers intense inflammation, which can harm the heart. Systemic inflammation post-AMI predicts poor outcomes, highlighting the need to understand immune system regulation.
Area of Science:
- Cardiovascular Science
- Immunology
- Pathophysiology
Background:
- Acute myocardial infarction (AMI) causes cardiomyocyte necrosis, releasing damage-associated molecular patterns.
- These patterns activate inflammatory pathways, including complement and toll-like receptor/interleukin-1 signaling.
- While inflammation aids heart repair, excessive responses contribute to adverse left ventricular remodeling and heart failure.
Purpose of the Study:
- To investigate the role of systemic inflammation in the context of acute myocardial infarction.
- To explore the mechanisms driving excessive inflammation and its consequences.
- To understand the link between systemic inflammation markers and clinical outcomes in AMI patients.
Main Methods:
- Analysis of inflammatory markers in patients with AMI.
- Investigation of immune system activation, including bone marrow and spleen.
- Correlation of systemic inflammation markers with clinical outcomes such as mortality and heart failure.
Main Results:
- AMI induces both local and profound systemic inflammatory responses.
- Systemic inflammation involves elevated cytokines, chemokines, cell adhesion molecules, and activated leukocytes/platelets.
- Bone marrow activation and spleen monocytopoiesis contribute to sustained monocyte supply at inflammation sites.
- Systemic inflammation is linked to aggravated atherosclerosis and predicts adverse clinical outcomes in AMI patients.
Conclusions:
- Excessive inflammation following AMI, potentially due to immune dysregulation, significantly impacts cardiac remodeling and prognosis.
- Systemic inflammation markers are crucial predictors of adverse outcomes in AMI.
- Further research into immune modulation in AMI is warranted to improve patient outcomes.
Related Concept Videos
01:21Myocarditis I: Introduction
605
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
605
01:28Acute Coronary Syndrome IV: Interprofessional Care
485
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
485
01:30Acute Coronary Syndrome I: Introduction
1.8K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
01:30Inflammatory Response I: Vascular and Cellular
19.1K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
19.1K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
778
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
778
01:27Myocarditis II: Clinical Features and Diagnostic Tests
452
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
452